| 000 | 01668 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517153629.0 | ||
| 264 | 0 | _c20170914 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1873-5835 | ||
| 024 | 7 |
_a10.1016/j.leukres.2017.05.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGopalakrishnapillai, Anilkumar | |
| 245 | 0 | 0 |
_aEpigenetic drug combination induces remission in mouse xenograft models of pediatric acute myeloid leukemia. _h[electronic resource] |
| 260 |
_bLeukemia research _c07 2017 |
||
| 300 |
_a91-97 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aAzacitidine _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aEpigenesis, Genetic _xdrug effects |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aGene Expression Profiling |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxamic Acids _xpharmacology |
| 650 | 0 | 4 | _aImmunoblotting |
| 650 | 0 | 4 |
_aIndoles _xpharmacology |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 | _aLeukemia, Myeloid, Acute |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aOligonucleotide Array Sequence Analysis |
| 650 | 0 | 4 | _aPanobinostat |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xanalysis |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aKolb, E Anders | |
| 700 | 1 | _aMcCahan, Suzanne M | |
| 700 | 1 | _aBarwe, Sonali P | |
| 773 | 0 |
_tLeukemia research _gvol. 58 _gp. 91-97 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.leukres.2017.05.004 _zAvailable from publisher's website |
| 999 |
_c27174684 _d27174684 |
||